CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to LONA

Lasofoxifene in combination with abemaciclib

Phase 3
LeonaBio, Inc. (LONA)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Apr '27
LONAPhase 3

Lasofoxifene in combination with abemaciclib Phase 3 Est. Readout

Lasofoxifene in combination with abemaciclib
Apr 2027~
CT.gov
00%
Competitive Landscape

2 competitors in Metastatic Breast Cancer

View Full Landscape
Drug Information

Target Indication

Metastatic Breast Cancer

Clinical Trial

NCT05696626

Last updated: 10/17/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.